BRPI0417029A - malaeto ou tosilado de 7-[4-(4-clorobenzilóxi) benzenossulfonil]-8-metóxi-3-metil-2,3,4,5-tetraidro- 1h-3-benzazepìnio como antipsicótico - Google Patents

malaeto ou tosilado de 7-[4-(4-clorobenzilóxi) benzenossulfonil]-8-metóxi-3-metil-2,3,4,5-tetraidro- 1h-3-benzazepìnio como antipsicótico

Info

Publication number
BRPI0417029A
BRPI0417029A BRPI0417029-6A BRPI0417029A BRPI0417029A BR PI0417029 A BRPI0417029 A BR PI0417029A BR PI0417029 A BRPI0417029 A BR PI0417029A BR PI0417029 A BRPI0417029 A BR PI0417029A
Authority
BR
Brazil
Prior art keywords
chlorobenzyloxy
benzenesulfonyl
tetrahydro
methoxy
antipsychotic
Prior art date
Application number
BRPI0417029-6A
Other languages
English (en)
Portuguese (pt)
Inventor
David Clapham
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BRPI0417029A publication Critical patent/BRPI0417029A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
BRPI0417029-6A 2003-11-28 2004-11-25 malaeto ou tosilado de 7-[4-(4-clorobenzilóxi) benzenossulfonil]-8-metóxi-3-metil-2,3,4,5-tetraidro- 1h-3-benzazepìnio como antipsicótico BRPI0417029A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds
PCT/EP2004/013416 WO2005051916A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics

Publications (1)

Publication Number Publication Date
BRPI0417029A true BRPI0417029A (pt) 2007-02-06

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417029-6A BRPI0417029A (pt) 2003-11-28 2004-11-25 malaeto ou tosilado de 7-[4-(4-clorobenzilóxi) benzenossulfonil]-8-metóxi-3-metil-2,3,4,5-tetraidro- 1h-3-benzazepìnio como antipsicótico

Country Status (18)

Country Link
US (1) US20070275948A1 (https=)
EP (1) EP1687279A1 (https=)
JP (1) JP2007512285A (https=)
KR (1) KR20060103322A (https=)
CN (1) CN1906170A (https=)
AR (1) AR046719A1 (https=)
AU (1) AU2004293179A1 (https=)
BR (1) BRPI0417029A (https=)
CA (1) CA2547444A1 (https=)
GB (1) GB0327740D0 (https=)
IL (1) IL175663A0 (https=)
IS (1) IS8500A (https=)
MA (1) MA28177A1 (https=)
NO (1) NO20062970L (https=)
RU (1) RU2006122959A (https=)
TW (1) TW200528433A (https=)
WO (1) WO2005051916A1 (https=)
ZA (1) ZA200603781B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
KR101653548B1 (ko) * 2008-01-08 2016-09-02 머크 샤프 앤드 돔 리미티드 2-｛4-［（3ｓ）-피페리딘-3-일］페닐｝-2ｈ-인다졸-7-카복스아미드의 약제학적으로 허용되는 염
US20180228811A1 (en) * 2014-12-12 2018-08-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
JP2022504228A (ja) 2018-10-03 2022-01-13 テサロ， インコーポレイテッド ニラパリブ遊離塩基の結晶形態
WO2022093904A1 (en) * 2020-10-27 2022-05-05 Trevena, Inc. Crystalline and amorphous forms of a delta-opioid modulator
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518414A (ja) * 2001-12-21 2005-06-23 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ドーパミン受容体のモジュレーターとしての７−スルホニル−３−ベンゾアゼピン誘導体およびｃｎｓ障害の治療のためのその使用
MXPA04007920A (es) * 2002-02-13 2004-11-26 Glaxo Group Ltd Derivados de bencensulfonamida como agentes antisicoticos.
AR040126A1 (es) * 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento

Also Published As

Publication number Publication date
TW200528433A (en) 2005-09-01
ZA200603781B (en) 2007-09-26
IL175663A0 (en) 2006-09-05
KR20060103322A (ko) 2006-09-28
EP1687279A1 (en) 2006-08-09
RU2006122959A (ru) 2008-01-10
WO2005051916A1 (en) 2005-06-09
US20070275948A1 (en) 2007-11-29
CA2547444A1 (en) 2005-06-09
AR046719A1 (es) 2005-12-21
AU2004293179A1 (en) 2005-06-09
MA28177A1 (fr) 2006-09-01
GB0327740D0 (en) 2003-12-31
JP2007512285A (ja) 2007-05-17
IS8500A (is) 2006-06-08
NO20062970L (no) 2006-08-21
CN1906170A (zh) 2007-01-31

Similar Documents

Publication Publication Date Title
ECSP045519A (es) Nuevos derivados de quinuclidina-amida
MEP25908A (bs) Derivati pirazolo-hinazolina, postupci za njihovo dobijanje i njihova upotreba kao inhibitor kinaze
UY30759A1 (es) Compuestos quimicos
TW200640908A (en) Chemical compounds
BRPI0410933A (pt) novos antagonistas do receptor p2x7 e seu uso
CY1113846T1 (el) Παραγωγα πυριμιδινης για την θεραπευτικη αντιμετωπιση του ασθματος, copd, αλλεργικης ρινιτιδας, αλλεργικης επιπεφυκιτιδας, ατοπικης δερματιτιδας, καρκινου, ηπατιτιδας β, ηπατιτιδας c, hiv, hpv, βακτηριακων λοιμωξεων και δερματωσης
SE0402735D0 (sv) Novel compounds
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
UY28059A1 (es) Nuevos derivados de dihidropirimido (4,5-d) pirimidona sustituida por amino. fabricacion y uso de los mismos como agentes farmaceuticos.
BRPI0507065A (pt) derivados de quinolina e seu uso como inibidores micobacterianos
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
EA200870545A1 (ru) Новые гетероциклические соединения
UY30183A1 (es) Derivados de quinolina
CL2012000231A1 (es) Formulacion farmaceutica que comprende (n-[2-(2,1,3-benzotiadiazol-5-ilamino)-6-(2,6-diclorofenil) pirido [2,3-d] pirimidin-7-il]-n'-(1,1-dimetil-urea) en una mezcla de tensioactivo / etanol en relacion de 25/75 a 80/20; solucion para perfusion; procedimientos de preparacion; y frascos de perfusion.
CY1111442T1 (el) Ενωσεις πιπεριδινης και χρησεις αυτων
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
BRPI0411891A (pt) pirazol[3,4-b]piridin-6-onas como inibidores de gsk-3
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
BRPI0417029A (pt) malaeto ou tosilado de 7-[4-(4-clorobenzilóxi) benzenossulfonil]-8-metóxi-3-metil-2,3,4,5-tetraidro- 1h-3-benzazepìnio como antipsicótico
DE60217843D1 (de) Ein dioxinoä2,3-güchinolin-9-carbonsäure derivat als nk3 rezeptor antagonist
AR033293A1 (es) Composiciones y metodos para aumentar la biodisponibilidad de agentes farmaceuticos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.